ArticleACS medicinal chemistry letters2026

Discovery of JH-XIII-05-01, a First-in-Class Dual IRAK1/IRAK4 Degrader for MYD88 Mutant Lymphomas.

John M Hatcher et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.